Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
Journal for Immunotherapy of Cancer|June 4, 2019
PD-L1 detection using <sup>89</sup>Zr-atezolizumab immuno-PET in renal cell carcinoma tumorgrafts from a patient with favorable nivolumab responseJoseph Vento, Aditi Mulgaonkar, Layton Woolford, et al.
International Journal of Radiation Oncology, Biology, Physics|December 19, 2020
Long-Term Results of a Phase 1 Dose-Escalation Trial and Subsequent Institutional Experience of Single-Fraction Stereotactic Ablative Radiation Therapy for Liver MetastasesMichael R Folkert, Jeffrey J Meyer, Todd A Aguilera, et al.
European Urology Oncology|January 6, 2022
Phase II Trial of Stereotactic Ablative Radiation for Oligoprogressive Metastatic Kidney CancerRaquibul Hannan, Michael Christensen, Hans Hammers, et al.
Clinical Genitourinary Cancer|September 16, 2018
Incidence and Outcomes of Delayed Targeted Therapy After Cytoreductive Nephrectomy for Metastatic Renal-Cell Carcinoma: A Nationwide Cancer Registry StudySolomon L Woldu, Justin T Matulay, Timothy N Clinton, et al.
Medical Physics|June 26, 2023
Bony structure enhanced synthetic CT generation using Dixon sequences for pelvis MR-only radiotherapyXiao Liang, Allen Yen, Ti Bai, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Immune stromal components impede biological effectiveness of carbon ion therapy in a preclinical model of pancreatic ductal adenocarcinomaKaty L Swancutt, Eslam A Elghonaimy, James H Nicholson, et al.
Molecular Cancer Therapeutics|October 14, 2025
Immune stromal components impede biological effectiveness of carbon ion therapy in a preclinical model of pancreatic ductal adenocarcinomaKaty L Swancutt, Eslam A Elghonaimy, James H Nicholson, et al.
Cancers|September 13, 2025
Clinical Implementation of PSMA-PET Guided Tumor Response-Based Boost Adaptation in Online Adaptive Radiotherapy for High-Risk Prostate CancerRuiqi Li, Mu-Han Lin, Nghi C Nguyen, et al.
International Journal of Radiation Oncology, Biology, Physics|August 5, 2019
Stereotactic Ablative Radiation Therapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell CancerYuanyuan Zhang, Jonathan Schoenhals, Alana Christie, et al.
Clinical Genitourinary Cancer|December 13, 2018
Improved Survival Outcomes for Kidney Cancer Patients With Brain MetastasesI Alex Bowman, Alisha Bent, Tri Le, et al.
Pageof 11